VARSAL TECH, INC.

S-1/A amended

Price $5.50 · Range $5.00 to $6.00 · 3,000,000 shares · Gross proceeds $16,500,000

S-1/A amended

Price $5.50 · Range $5.00 to $6.00 · 3,000,000 shares · Gross proceeds $16,500,000

Varsal Tech, Inc. outlines its strategic expansion into Saudi Arabia, aiming to establish a subsidiary with a $100 million project focused on leveraging regional feedstocks for cost-advantaged production. The company reports a decline in six-month 2026 revenues due to reduced sales volumes from key customers, though gross margins improved significantly through production optimizations and cost reductions. Operational expenses rose due to IPO-related costs, while income from operations increased despite these pressures. The company faces risks related to customer concentration, geopolitical uncertainties, and trade tariffs affecting U.S. markets.

S-1/A amended

Varsal Tech, Inc. is expanding its manufacturing capabilities in the Middle East, specifically Saudi Arabia, aiming to establish a $100M subsidiary with a majority equity stake. The company reported a 31% revenue decline to $8.1M for the six months ended March 31, 2026, driven by reduced sales of pharmaceutical intermediates, though gross margins improved to 62% due to production optimizations. Financial results show increased operating income, while strategic shifts include moving specialty chemicals production from China to the U.S. to mitigate trade tariffs. The filing highlights risks from customer concentration, supply chain disruptions, and geopolitical uncertainties.

S-1 filed

Varsal Tech, Inc. is preparing for its IPO, highlighting its reliance on key customers and suppliers, supply chain vulnerabilities, and expansion plans. The company faces risks from customer concentration, supplier dependencies, and global economic disruptions. It plans to expand manufacturing in the U.S. and Middle East to enhance supply chain resilience and capture regional growth. Financial performance shows fluctuating revenues and improved gross margins due to production optimizations, but challenges persist from trade tensions and regulatory changes.

DRS/A amended

Varsal Tech, Inc. filed a DRS/A form for its IPO, detailing restructuring activities, financial performance, and underwriting terms. The company restructured by merging with Varsal LLC, resulting in updated financial statements and equity adjustments. The filing highlights strong revenue growth, net income, and preparations for an IPO, including underwriting agreements and lock-up provisions. The company operates in specialty chemicals and pharmaceuticals, with a focus on U.S. and international markets.

DRS filed

VARSAL TECH, INC. is conducting an initial public offering (IPO) of Class A Common Stock, with underwriters acting as representatives. The offering includes an over-allotment option, underwriting discounts, and lock-up agreements for insiders. The company intends to list on NYSE American, though approval is pending. Tax implications under FATCA and potential market stabilization activities by underwriters are noted.